Shanghai Chest Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1957-01-01
- Employees
- -
- Market Cap
- -
A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLC
- Conditions
- NSCLCMalignant Hydrothorax
- Interventions
- Diagnostic Test: in vitro NGS-panel
- First Posted Date
- 2018-06-06
- Last Posted Date
- 2018-06-07
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT03546452
- Locations
- 🇨🇳
Shangha Chest Hospital, Shanghai, Shanghai, China
EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual Progression
Phase 2
Completed
- Conditions
- Lung AdenocarcinomaEGFR Activating Mutation
- Interventions
- Drug: first icotinib and then pemetrexed plus cisplatin
- First Posted Date
- 2018-06-04
- Last Posted Date
- 2019-10-15
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 99
- Registration Number
- NCT03544814
Hypofractionated vs. Conventionally Fractionated Concurrent CRT for Unresectable Stage III NSCLC
Phase 3
- Conditions
- Unresectable Stage III Non-small-cell Lung Cancer
- Interventions
- Radiation: Arm1 (Hypofractionated radiotherapy)
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 480
- Registration Number
- NCT03331575
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted Therapy
Not Applicable
Completed
- Conditions
- Lung Cancer
- Interventions
- Device: Miseq sequencer
- First Posted Date
- 2017-10-13
- Last Posted Date
- 2019-12-09
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT03309462
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Robot-assisted Esophagectomy Versus Conventional Thoracoscopic Esophagectomy
Phase 3
Recruiting
- Conditions
- Esophageal CarcinomaEsophageal Cancer
- Interventions
- Procedure: esophagectomy
- First Posted Date
- 2017-03-29
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 360
- Registration Number
- NCT03094351
- Locations
- 🇨🇳
General hospital of eastern theater command, Nanjing, Jiangsu, China
🇨🇳Changhai Hospital, The Second Military Medical University, Shanghai, China
🇨🇳The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
ENB Guided RFA for Early-stage Peripheral Lung Cancer
Not Applicable
- Conditions
- Lung Cancer
- Interventions
- Procedure: RFADevice: ENB
- First Posted Date
- 2017-01-04
- Last Posted Date
- 2017-01-06
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT03009630
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC
Phase 3
- Conditions
- SCLC
- Interventions
- Radiation: Accelerated hypofractionated concurrent chemo-radiotherapyRadiation: Conventionally fractionated concurrent chemo-radiotherapy
- First Posted Date
- 2016-12-13
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 266
- Registration Number
- NCT02990780
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer
Phase 2
- Conditions
- Non-small Cell Lung Cancer Stage IIIARadiotherapy
- Interventions
- First Posted Date
- 2016-11-30
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT02977169
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer
Phase 2
- Conditions
- NSCLC
- Interventions
- Radiation: Conventional Fractionated RadiotherapyRadiation: Stereotactic Body Radiation Therapy
- First Posted Date
- 2016-11-29
- Last Posted Date
- 2016-11-29
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT02975609
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer
Phase 3
Terminated
- Conditions
- Non-small Cell Lung Cancer Stage IIIARadiotherapy
- Interventions
- Radiation: PORT-lastRadiation: PORT-first
- First Posted Date
- 2016-11-28
- Last Posted Date
- 2024-06-12
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 132
- Registration Number
- NCT02974426
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath